CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 82.12% of retail investor accounts lose money when trading CFDs. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money
6.9130
4.88%
Market Trading Hours* (UTC) Opens on Monday at 08:00

Mon - Fri: 08:00 - 16:30

  • Summary
  • Historical Data
Trading сonditions
Spread 0.0340
Long position overnight fee

Long position overnight funding adjustment


Margin. Your investment $1,000.00
Overnight funding adjustment -0.023252 %
Charges from full value of position ($-4.42)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.023252%
Short position overnight fee

Short position overnight funding adjustment


Margin. Your investment $1,000.00
Overnight funding adjustment 0.001334 %
Charges from full value of position ($0.25)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
0.001334%
Overnight fee time 22:00 (UTC)
Min traded quantity 1
Currency GBP
Margin 5.00%
Stock exchange United Kingdom of Great Britain and Northern Ireland
Commission on trade 0%

Key Stats
Prev. Close 7.2675
Open 7.0925
1-Year Change -46.22%
Day's Range 6.753 - 7.1025
  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Feb 21, 2025 6.9130 -0.2995 -4.15% 7.2125 7.2525 6.7080
Feb 20, 2025 7.2675 0.4495 6.59% 6.8180 7.5920 6.2985
Feb 19, 2025 8.5560 0.0350 0.41% 8.5210 8.5560 8.2365
Feb 18, 2025 8.4560 0.2545 3.10% 8.2015 8.4865 8.1865
Feb 17, 2025 8.0565 0.3695 4.81% 7.6870 8.2315 7.5620
Feb 14, 2025 7.8420 -0.0100 -0.13% 7.8520 8.0665 7.8170
Feb 13, 2025 7.8770 -0.0795 -1.00% 7.9565 8.0765 7.6570
Feb 12, 2025 8.0365 0.0900 1.13% 7.9465 8.3265 7.8270
Feb 11, 2025 7.7070 0.1950 2.60% 7.5120 7.7720 7.4120
Feb 10, 2025 7.4920 -0.0150 -0.20% 7.5070 7.7320 7.3225
Feb 7, 2025 7.7970 -0.5445 -6.53% 8.3415 8.4265 7.6970
Feb 6, 2025 8.4160 -0.2150 -2.49% 8.6310 8.7510 8.2015
Feb 5, 2025 8.5660 -0.5745 -6.29% 9.1405 9.2305 8.5660
Feb 4, 2025 9.0405 -0.3845 -4.08% 9.4250 9.4305 9.0205
Feb 3, 2025 9.2155 -0.1150 -1.23% 9.3305 9.5400 9.0355
Jan 31, 2025 9.5200 -0.1550 -1.60% 9.6750 9.9450 9.3755
Jan 30, 2025 9.7650 0.1550 1.61% 9.6100 9.9050 9.5550
Jan 29, 2025 9.6850 0.1200 1.25% 9.5650 9.9845 9.5350
Jan 28, 2025 9.6700 0.0950 0.99% 9.5750 9.9800 9.4650
Jan 27, 2025 9.5900 0.2195 2.34% 9.3705 9.7950 9.3255

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
  • 2:1
  • 3:1
  • 5:1
  • 10:1
  • 20:1
Leverage
20:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long

For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

Indivior Company profile

About Indivior PLC

Indivior PLC is a United Kingdom-based pharmaceutical company. The Company is engaged in developing medicines to treat addiction and serious mental illnesses. It focuses to build a portfolio of opioid dependence treatments. It has a pipeline of product candidates designed to address other chronic conditions and cooccurring disorders of addiction, including alcohol use disorder. Its product pipeline focuses on development and discovery of non-opioid treatment strategies for opioid use disorder (OUD), as well as new therapies to address the needs of people suffering from alcohol, stimulant and cannabis use disorders. Its pipeline products include INDV-3000 - Selective Dopamine D3-receptor Antagonist, RBP-6000 - Buprenorphine XR injection, Buprenorphine/ Naloxone Sublingual Film, Buprenorphine/ Naloxone Sublingual Tablet and Buprenorphine Sublingual Tablet, among others. Its portfolio of products is available in more than 40 countries.

Financial summary

BRIEF: For the fiscal year ended 31 December 2021, Indivior PLC revenues increased 22% to $791M. Net income totaled $205M vs. loss of $148M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Net Income reflects Other operating income increase from $0K to $32M (income), Selling/General/Admin. Expense, decrease of 5% to $192M (expense).

Industry: Proprietary & Advanced Pharmaceuticals

234 Bath Road
SLOUGH
BERKSHIRE SL1 4EE
GB

People also watch

XRP/USD

2.59 Price
+2.170% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 22:00 (UTC)
Spread 0.01294

US100

21,594.40 Price
-2.120% 1D Chg, %
Long position overnight fee -0.0235%
Short position overnight fee 0.0013%
Overnight fee time 22:00 (UTC)
Spread 7.0

BTC/USD

96,694.45 Price
+1.400% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 22:00 (UTC)
Spread 50.00

ETH/USD

2,760.24 Price
+4.610% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 22:00 (UTC)
Spread 1.75

Still looking for a broker you can trust?

Join the 690,000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading